About Index Trending news
Analyze
Pricing
Apellis Pharma

Apellis Pharma

Work at Apellis Pharma? Add yourself to this profile

Apellis Pharma

Small Biotech Focusing on Complement Immunotherapy
Edit Profile
More info

Elsewhere

Companies in the same industry

AgeneBio AgeneBio Bioheart Bioheart Entelos Entelos Morphogen-IX Morphogen-IX LAM Therapeutics LAM Therapeutics Emerus Hospital Partners Emerus Hospital Partners GLO Science GLO Science InSite Vision InSite Vision Molplex Molplex Laurantis Pharma Laurantis Pharma

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
Latest funding
Venture capital (Series D)
$47,100,000
Hillhouse Capital Group, Epidarex Capital, Cormorant Asset Management, +3
Venture capital (Series D)
$32,000,000
Employees

Unknown size

Locations
HQ
United States
Headquarters
$47,100,000 Venture capital (Series D)
FinSMEs

Apellis Pharmaceuticals Completes $47.1M Series D Financing

Health Funding
Apellis Pharma
Apellis Pharma
$32,000,000 Venture capital (Series D)
venturedeal

Apellis Pharma Accepts $32 Million Equity VC

Apellis Pharma
Apellis Pharma